This bill would create at least five "innovative therapies centers of excellence" inside Department of Veterans Affairs (VA) medical facilities. The centers would focus on research, education, and clinical work related to certain "innovative therapies" and specific health conditions. The VA Secretary, after advice from the Under Secretary for Health, must pick the locations and try to spread them across the country. A peer review panel made up of experts in innovative therapies would rate proposals and recommend the strongest ones. Each chosen facility must meet several requirements, including partnerships with an accredited medical school that trains residents in these therapies, an accredited school of psychiatry, and an accredited school of social work. Centers must have advisory committees that include veterans, ways to evaluate their own work, plans to share training and care across the VA system, and a plan to make a national data repository. The bill lists covered conditions (for example: anxiety, bipolar disorder, chronic pain, depression, Parkinson’s disease, PTSD, and substance use disorder) and lists specific innovative therapies (for example: MDMA, 5-MeO-DMT, ibogaine, ketamine, psilocybin). The Under Secretary for Health must report to the Veterans' Affairs committees starting two years after enactment and then every year. The bill also authorizes $30,000,000 per fiscal year for the research and education work of these centers and allows the Under Secretary to allocate additional VA funds as appropriate.
The bill directs the VA to set up centers to study, teach, and provide care related to a set list of innovative therapies and covered conditions. It requires peer review selection, academic partnerships, veteran advisory committees, a national data repository, and annual reporting to Congress. Sponsors and the text frame the measure as a way to organize research, training, and clinical work on these therapies within the VA system.
No publicly available information.